FDA Adverse Event Injury Summary report: N

NOVOPEN JUNIOR

MDR report key: 3767462 · Received April 15, 2014

Report

Report Number
9681821-2014-00015
Event Type
Injury
Date Received
April 15, 2014
Date of Event
March 17, 2014
Report Date
March 14, 2014
Manufacturer
NOVO NORDISK A/S
Product Code
KZH
PMA / PMN Number
19-938
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 1

EVENT VERBATIM [PREFERRED TERM] (RELATED SYMPTOMS IF ANY SEPARATED BY COMMAS) PUSH BUTTON WILL NOT DEPRESS [DEVICE MALFUNCTION] ([BLOOD GLUCOSE INCREASED]). CASE DESCRIPTION: DOES THE INCIDENT REPRESENT A SERIOUS PUBLIC HEALTH TREAT? NO. THIS SERIOUS SPONTANEOUS CASE FROM THE UNITED STATES WAS REPORTED BY A MOTHER AND A FRIEND OF THE MOTHER'S. AS "PUSH BUTTON WILL NOT DEPRESS" AND "HIGH BLOOD SUGAR" BEGINNING ON (B)(6) 2014, AND CONCERNED A (B)(6) OLD MALE PT USING NOVOPEN JUNIOR (INSULIN DELIVERY DEVICE) FROM (B)(6) 2013 TO ONGOING, DUE TO TYPE 1 DIABETES MELLITUS. MEDICAL HISTORY INCLUDED TYPE 1 DIABETES MELLITUS DIAGNOSED ON (B)(6) 2013. THE PT HAD NO OTHER MEDICAL CONDITIONS. A MOTHER REPORTED THAT HER SON WAS BEING TREATED WITH NOVOLOG PENFILL SLIDING SCALE, WITH NOVOPEN JUNIOR, FROM (B)(6) 2013. ON (B)(6) 2014, THE PUSH BUTTON WOULD NOT DEPRESS ON THE NOVOPEN JUNIOR, AND AS A RESULT, THE PT WAS HOSPITALIZED WITH HIGH BLOOD SUGAR THAT SAME DAY. THE PT HAD BLOOD SUGAR READINGS ON THE 400'S MD/DL AND 500'S MG/DL. THE PT WAS TREATED WITH NOVOLOG IN THE HOSPITAL. LATER THAT DAY ON (B)(6) 2014, THE PT RECOVERED AND WAS DISCHARGED HOME FROM THE HOSPITAL. ACTION TAKEN TO NOVOPEN JUNIOR WAS REPORTED AS NO CHANGE. THE OUTCOME FOR THE EVENTS WAS REPORTED AS RECOVERED ON (B)(6) 2014.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
230834 NOVOPEN JUNIOR INSULIN DELIVER DEVICE KZH NOVO NORDISK A/S NA NV403189

Patients

Seq Age Sex Outcome Treatment
1 5 YR Hospitalization NOVOLOG PENFILL (INSULIN ASPART) SOLUTION| LANTUS (INSULIN GLARGINE)| FOR INJECTION, 100 U/ML (B)(6) 2013 TO ONGOING